Named on 4 rounds in the feed.
Rounds from 2021-06-15 to 2026-11-11
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
VectorY Therapeutics A clinical-stage biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases | Series A Verified against 1 of 10 sources | $82.9M | 2026-11-11 | [ PART ] |
Goodweek A one-stop AI management platform for small and medium-sized businesses | Seed Verified against 1 of 16 sources | $12M | 2026-10-15 | [ PART ] |
Ascerta Ascerta provides AI performance measurement and transformation solutions for enterprises. | Series A Verified against 4 of 28 sources | $18M | 2026-09-29 | [ PART ] |
VectorY Therapeutics A clinical-stage biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $37.5M | 2021-06-15 | [ PART ] |